All In MedTech

FDA Clearance Tracker · P230003-S015

Alinity m HR HPV

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P230003-S015
Device name
Alinity m HR HPV
Applicant location
Des Plaines, IL
Received
Mar 30, 2026
Decided
Jul 23, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P230003

Device type

Device class
Class III

Every decision under product code MAQ

FDA's approval statement

As written in FDA's record.

Requested a site change for the P230003/S015

Source documents

Other decisions for Abbott Molecular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.